Integral Health Asset Management »

Alto Neuroscience shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 400k 4.02
2025-06-30 $880k 400k 2.20
2025-03-31 $864k 400k 2.16
2024-12-31 $1.3M 300k 4.23

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Alto Neuroscience

Falcon Edge Capital
Armistice Capital
Point72 Asset Management
Franklin Resources
Vanguard Group
Vestal Point Capital
Marshall Wace
72 Investment Holdings
Alkeon Capital Management
Northern Trust
Integral Health Asset Management
BlackRock
Millennium Management
Peapod Lane Capital
AWM Investment Company

View all funds holding Alto Neuroscience